Why the study?
This study was conducted to analyze adherence to antihypertensive drugs and identify factors associated with drug adherence in Chinese patients with hypertension.
Do specific antihypertensive drugs and socioeconomic factors improve treatment adherence in Chinese patients with hypertension?
Do specific antihypertensive drugs and socioeconomic factors improve treatment adherence in Chinese patients with hypertension?
Answers are grounded in this paper and cite their sources.
In Chinese patients with hypertension, adherence is highest with long-acting agents like nifedipine controlled release and is positively influenced by higher reimbursement ratios and lower daily medical costs.
Objective: To analyze the adherence to antihypertensive drugs in Chinese patients with hypertension and the factors associated with the drug adherence. Methods: The data for this analysis were obtained from the 2014 China Health Insurance Association (CHIRA) database. The study included 64,576 patients aged ≥ 18 years who were prescribed one of the seven antihypertensive drugs included in the study in their first prescription in 2014 and were observed for ≥ 180 days. The medicine possession ratio (MPR) was calculated and taken as the measure of treatment adherence. MPR values < 0.3, 0.3 to < 0.5, 0.5 to < 0.8, and ≥ 0.8 were considered treatment adherence very low, low, intermediate, and high, respectively. Descriptive statistics were used to present baseline data and treatment adherence rate. Multiple regression models were used to determine independent factors which can affect the treatment adherence rate. P -value < 0.05 was considered significant. Results: Among the study antihypertensive drugs, amlodipine (33.98%), metoprolol (25.04%), and nifedipine (17.15%) were the frequently prescribed drugs. Nifedipine controlled release tablet had the highest MPR (0.61), followed by valsartan (0.53), valsartan/amlodipine fixed-dose combination (0.50), indapamide (0.40), and amlodipine (0.39), whereas benazepril (0.27) and metoprolol (0.19) had the lowest MPR. Higher reimbursement ratio, regular tertiary hospitals visits, lower age, and lower daily medical cost positively affected treatment adherence, whereas longer duration of illness and higher daily average cost affected treatment adherence negatively. Conclusion: Our study assessed that prescribing more cost-effective, long-acting antihypertensive drugs, and raising the reimbursement ratio were associated with a better treatment adherence in Chinese patients with hypertension.
No takes yet. Share an insight, caveat, or question.
Cui et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: